Phase 2 N=11 A Study of Deucravacitinib to Treat LPP and FFA
Lichen Planopilaris
Primary: Complete and Partial Response to Deucravacitinib Measured by Lichen Planopilaris Activity Index (LPPAI) Score — 9 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=45 A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial
Hidradenitis Suppurativa
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 15; 28 Participants
Phase 3 N=26 24 Hour Ambulatory Cardiac Oxygen Consumption
Hypertension
Primary: ACRPP: 24-hour Ambulatory Central Rate-pressure Product (Also Called TTI, CTTI) — 2531; 2824; 2484 mmHg*beats/min — p=0.05
N/A N=97 Reopening Schools Safely and Educating Youth Research- Early Learning Ancillary Study
Absenteeism
Primary: Testing — 41; 8; 0; 0 Participants
N/A N=1,260 Cannabis Edibles Packaging Imagery Experiment
Cannabis Use
Primary: Product Appeal Scoring — 5.54; 6.11; 5.73; 5.70 Score on a scale
Phase 2 N=25 Study of NKTR 255 in Combination With Cetuximab in Solid Tumors
Head and Neck Squamous Cell Carcinoma · Colorectal Cancer
Primary: Incidence of Treatment-Emergent Adverse Events (TEAE) and Serious Adverse Events (SAE) of NKTR-255 in Combination With Cetuximab in R/R HNSCC or CRC for Phase 1b Dose…
N/A N=29 Engaging Suicidal Patients in Mental Health Treatment
Suicide · Depression · Mental Health Impairment
Primary: Acceptability of Intervention Measure (AIM) — 3.96; 4.40; 3.88; 3.34 score on a scale
N/A N=198 A Dyadic Approach for a Remote Physical Activity Intervention in Adults With AD and Their Caregivers
Alzheimer Disease
Primary: Moderate Physical Activity — 13.3; 20.7; 14.4; 19.3 minutes per day
N/A N=35 Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System
Peripheral Arterial Disease
Primary: Primary Safety: Major Adverse Events (MAE) — 1; 1; 0; 0 participants — p=<.025
N/A N=727 Improving Quality of Care in Child Mental Health Service Settings
Post Traumatic Stress Disorder · Technology · Child Abuse
Primary: Child Involvement Ratings Scale (CIRS) — 1.95; 2.01 units on a scale
N/A N=25 Insomnia Prevention in Children With Acute Lymphoblastic Leukemia
Pediatric Acute Lymphoblastic Leukemia · Leukemia · Acute Lymphoblastic Leukemia
Primary: Enrollment Rate of Participants — 25 Participants
N/A N=105 Leveraging Home Health Aides to Improve Outcomes in Heart Failure
Heart Failure · Congestive Heart Failure
Primary: Change in Heart Failure Knowledge — 0.93; 1.88 units on a scale
Phase 4 N=1,051 Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California
Vaccine Refusal · Covid19
Primary: Change in Vaccine Hesitancy — 282; 387; 57; 48 Participants
N/A N=11 SpO2 Accuracy of Noninvasive Pulse Oximeter Sensor With Motion Conditions
Healthy · Hypoxia
Primary: Accuracy of Sensor by Comparing SpO2 Percent Blood Oxygen Saturation to SaO2 Percent Blood Oxygen Saturation Utilizing Arms Calculation Calculation [Time Frame: 1 - 5…
N/A N=488 The LEADLESS Observational Study
Indications for VVI(R) Pacemaker
Primary: Complication Free-rate — 16; 284 Participants